Avanos Medical (AVNS) Total Non-Current Liabilities (2013 - 2026)

Avanos Medical has disclosed Total Non-Current Liabilities across 14 years of filings, most recently posting $253.9 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities fell 3.79% year-over-year to $253.9 million; the TTM figure through Mar 2026 stood at $253.9 million (down 3.79% YoY), while the FY2025 annual figure was $282.0 million, down 12.23% from the prior year.
• Total Non-Current Liabilities came in at $253.9 million for Q1 2026 at Avanos Medical, down from $282.0 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $487.2 million in Q3 2023 to a low of $253.9 million in Q1 2026.
• Average Total Non-Current Liabilities over 5 years is $388.1 million, with a median of $420.7 million recorded in 2023.
• Year-over-year, Total Non-Current Liabilities surged 48.48% in 2022 and slumped 39.24% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $475.2 million in 2022, then slipped by 6.12% to $446.1 million in 2023, then declined by 27.98% to $321.3 million in 2024, then decreased by 12.23% to $282.0 million in 2025, then slipped by 9.96% to $253.9 million in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $253.9 million in Q1 2026, $282.0 million in Q4 2025, and $269.0 million in Q3 2025.